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Recent in vivo studies suggest that hMPV is a poor inducer of inflammatory cytokines and that clinical symptoms may not be related to
immune-mediated pathogenesis as it has been proposed for respiratory syncytial virus (RSV) and human parainfluenza 3 (HPF3). Dendritic cells
(DCs) are specialized antigen presenting cells, and very effective at inducing specific CTLs after encountering invading viruses. Interactions of
hMPV with DCs have not been characterized. We hypothesized that the relatively mild inflammatory responses observed in vivo after hMPV
infection might be at least in part due to hMPV's poor ability to stimulate and activate DCs. hMPV actively infected immature monocyte-derived
CD11c+/HLA-DR+ DCs. However, in contrast to RSV or HPF3, hMPV caused no gross cytopathic effects such as syncytia, lytic infection, or
massive apoptosis. DCs exposed to hMPV show no cytopathic effects under tissue culture conditions permissive for viral replication. The surface
maturation markers CD83 and CD86 were not significantly up-regulated in infected DCs as compared to uninfected controls, while expression of
CD80 appeared increased. Stimulation of hMPV-infected DCs with LPS resulted in the enhanced expression of all these surface markers
indicating that hMPV is not generally suppressing DC maturation. Overall, cytokine expression remained low. These results indicate that hMPV
does not induce effective DC maturation in vitro and suggest that the weak stimulation of DCs may account for the overall low immunogenicity of
this virus observed in vivo.
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Human Metapneumovirus (hMPV) is a newly identified
member of the Paramyxoviridae family, subfamily Pneumo-
virinae. Initially reported in the Netherlands in 2001 (van den
Hoogen et al., 2001), it has since been found in many areas of
the world including North America, Europe, Asia and Australia.
Epidemiological studies indicate that hMPV may account for
7–15% of acute respiratory tract infections in children, making
it second only to RSV (Bastien et al., 2003; Boivin et al., 2003;⁎ Corresponding author.
E-mail address: luca.gusella@mssm.edu (G. Luca Gusella).
0042-6822/$ - see front matter © 2006 Elsevier Inc. All rights reserved.
doi:10.1016/j.virol.2006.08.004Esper et al., 2003; Falsey et al., 2003; Jartti et al., 2002; Maggi
et al., 2003; Nissen et al., 2002; Stockton et al., 2002).
HMPV shares many structural, genetic, and epidemiological
similarities with the closely related respiratory syncytial virus
(RSV) and presents with similar clinical manifestations
including bronchiolitis and pneumonia. Like RSV, hMPV
causes respiratory infections that fail to elicit long lasting
protective immune responses, with reinfection occurring
through adult life (Bastien et al., 2003; Boivin et al., 2002,
2003; Christensen et al., 2003; Esper et al., 2003; Falsey et al.,
2003; Jartti et al., 2002; Maggi et al., 2003; Nissen et al., 2002;
Stockton et al., 2002; van den Hoogen et al., 2001). Because of
the recent recognition of hMPV, little is known about this virus
immunity and immunopathology. Interestingly, recent in vivo
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cytokines and that clinical symptoms may not be related to
immune-mediated pathogenesis as it has been proposed for
RSV (Laham et al., 2004). Hence, the immunobiology of RSV
and hMPV may be distinct and these viruses may cause similar
clinical symptoms by alternative mechanisms (Laham et al.,
2004).
Dendritic cells (DCs) are specialized antigen presenting cells
found in most tissues. DCs are often the first immune cells to
come in contact with infecting viruses after infection,
particularly after mucosal exposure, and can became primary
targets of infection. In most cases following viral infection, DCs
mature and become very effective in the induction of viral
specific CTLs, which in turn clear the infected cells. Therefore,
viral interference with DCs functions represents an ideal
mechanism to disrupt host immune responses (Andrews et al.,
2001; Bender et al., 1998; Cella et al., 1999; Salio et al., 1999;
Yewdell and Hill, 2002). Modulation of DCs by respiratory
paramyxoviruses is currently an important area of investigation
because of these cells privileged mucosal location and their
pivotal role in determining T helper lymphocyte (Th)
polarization.
The interactions of hMPV with DCs and the susceptibility of
DCs to infection have not been fully characterized. In this study,
we hypothesized that the relatively mild inflammatory responses
observed in vivo after hMPV infection might be at least in part
due to hMPV's inefficiency to stimulation and activation of
DCs. We provide the first evidence that hMPV actively infects
monocyte derived DCs and results in productive infectious viral
progeny. However, differently from RSV or human parain-
fluenza 3 (HPF3), hMPV infection of myeloid DCs causes no
gross cytopathic effects and fails to efficiently mature DCs.
These results indicate that hMPV fails to induce full DC
maturation in vitro, and suggest that the weak stimulation of DCs
may account for the low immunogenicity of hMPV in vivo.
Results
Human myeloid DCs exposed to hMPV show no cytopathic
effects under tissue culture conditions permissive for viral
replication
Even under optimal conditions in tissue culture, hMPV
exhibits slow growth with delayed evidence of syncytia
formation and cytopathic effects (average of 7–10 days post
inoculation), and requires the addition of trypsin to the media
to efficiently propagate (Biacchesi et al., 2004; van den
Hoogen et al., 2001). Because of these strict growth
requirements, we first assessed whether the culture conditions
necessary to grow hMPV were suitable for DCs. This
assessment was particularly important because infected DC
cultures needed be kept for extended periods of time after
infection (at least 7 days) to allow sufficient time for hMPV
replication and spreading.
After differentiation for 7 days in complete RPMI containing
serum and cytokines (see Materials and methods), immature
CD11c+/HLA-DR+ DCs were placed in enriched serum-freemedia supplemented with 2.5 μg/ml trypsin and cytokines. DCs
were observed daily under light microscopy for 7 days to
monitor for signs of toxicity such as abnormal cell morphology,
or cell death and cellular debris. Under these growth conditions,
DCs appeared morphologically normal with a viability over
95% as assessed by trypan blue exclusion.
To determine whether DCs were susceptible to hMPV
infection, cells were infected at an MOI of 0.01 (Biacchesi
et al., 2004) in OptiMEM supplemented with 1 μg/ml and
cytokines, and cultured for an additional 7 days to allow
viral replication and spread. LLC-MK2 cells, which are
permissive for viral growth, were infected in parallel under
the same culture conditions (except cytokines). Characteristic
hMPV cytopathic effects in permissive cell lines such as
LLC-MK2 include the presence of syncytia and rounded
floating cells. These effects appeared as early as 4–5 days
postinfection (Fig. 1A) and resulted in severe disruption of
the integrity of the cellular monolayer by day 7 as compared
to control uninfected LLC-MK2 cells (Fig. 1B). However,
gross cytopathic effects and syncytia formation were not
observed in infected DC cultures, which 7 days postinfec-
tion appeared as viable as uninfected controls (Figs. 1C and
D). More sensitive assessment of cell viability indicated an
increase in annexinV+ cells following infection for 7 days
(Fig. 1E). Though these results did not reach statistical
significance (p<0.066), there seems to be a trend of the
hMPV-infected cells toward apoptosis.
DCs are permissive for hMPV replication and infection results
in the release of very low titers of infectious virions
To evaluate whether DCs can support active viral replication
of hMPV, we assessed the expression of the F viral protein in
DCs 7 days after infection with hMPV at an MOI of 0.01.
LLC-MK2 cells, which infected in parallel to DCs and cultured
under the same conditions showed massive infection with high
cytopathicity after 7 days, were used as positive control.
Uninfected DCs and LLC-MK2 cells were used as negative
controls. The hMPV/F protein was immunodetected using anti-
F hMPV monoclonal antibodies developed in Armenian
hamster (Schickli et al., 2005). As shown in Fig. 2, the
expression of the viral F protein was readily detectable in
hMPV-infected DCs, indicating that these cells supported
hMPV replication. A predominant band, representing the
unprocessed F0, as well as a smaller band, consistent with the
cleaved F1 protein, was detected as previously described
(Schickli et al., 2005). In all the infected cells, we also observed
some lighter bands at higher molecular weight, which remain
uncharacterized. Although DCs were permissive for hMPV
growth, LLC-MK2 cells supported significantly higher amounts
of viral protein synthesis (note that 100 ng of LLC-MK2 vs.
10 μg of DC extracts were loaded) (Fig. 2). In fact, 7 days
postinfection, viral replication in LLC-MK2 cells appeared to
have taken over the host synthetic machinery as demonstrated by
the dramatic reduction of actin expression (Fig. 2). Furthermore,
the majority of hMPV/F in DCs appeared to remain unprocessed
(F0/F1DC>F0/F1LLC-MK) as compared to LLC-MK2 cells,
Fig. 1. hMPV infection is not cytopathic to DCs under culture conditions permissive for hMPV replication. Monocyte-derived DCs were cultured in RPMI
supplemented with 10% FBS and cytokines for 7 days to allow full differentiation, and then placed in serum-free medium (OptiMEM) supplemented with cytokines
and trypsin (2.5 μg/ml) (see Materials and methods). LLC-MK2 cells infected with hMPVat 0.01 MOI (A) and uninfected control (B) were maintained under the same
culture conditions of DCs for 7 days. While the mock-infected LLC-MK2 cells grew as intact monolayer, hMPV-infected cells clearly presented characteristic
cytopathic effects, such as formation of syncytia and dying small rounded cells at 7 days postinfection. Cultures of DCs infected in parallel with hMPV at the same
MOI (C) or mock-infected control (D) showed no gross viral cytopathic effects after 7 days in serum-free conditions. (E) Staining for annexinV indicated a tendency of
hMPV-infected DCs to apoptose after 7 days in culture cells (p<0.066). Treatment of DCs with CoCl2 for 12 h, which was shown to induce apoptosis (Manome et al.,
1999), was performed as positive control. Shown are means±SEM of experiments from four different donors.
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lack of syncytia formation in DCs.
To assess whether the virus was able to spread in DC cultures,
infected and uninfected DC controls were collected 7 days
postinfection and immunostained with an anti-hMPV/F mono-
clonal antibody and FITC-conjugated secondary antibody.
Quantification of hMPV/F protein surface expression by FACS
analysis indicated that, by day seven, hMPV had spread to 30–
40% of the cells (Fig. 3A). To determine whether DCs supported
productive infection, we analyzed the number of plaque forming
units (pfu) in the supernatants of DCs infected with hMPVat an
MOI of 0.01. At day 1 and 3 postinfection, no infectious particle
was rescued from any infected DCs culture. However, by day 7
postinfection, viable virions were readily detected in the
supernatants of two out of four donors suggesting the ability of
DCs to sustain productive hMPV infection (Fig. 3B). To assess
the extent of viral release in supernatants following hMPV
infection of DCs, viral titers were measured by plaque assays.
Supernatants collected from LLC-MK cells maintained inparallel under the same conditions were used as controls. As
shown in Fig. 3C, infected DCs released viable infectious viral
progeny into the supernatants, although titers were on average
two logs lower than those obtained from supernatants derived
from LLC-MK2 cells infected and harvested under the same
conditions (2.5×102 vs. 250×102 pfu/ml). This 100-fold
difference parallels the expression of the hMPV/F protein
observed in DCs and LLC-MK2 by immunoblot as shown
above. As expected due to donor variability, the viral titers from
different preparations fluctuate over a wide range, but virus
release did not appear to correlate with apoptosis (Fig. 3D).
HMPV infection does not induce efficient maturation of DCs
Effects of hMPV infection on DC maturation were
determined by analysis of the expression of CD80, CD83, and
CD86 surface markers. Uninfected DCs unstimulated or
stimulated with LPS (1 μg/ml) were used as negative and
positive control, respectively. Despite the presence of viral
Fig. 2. DCs support hMPV viral protein synthesis. Non-infected cells (−) or cells
infected with hMPV at a 0.01 MOI (+) were cultured for 7 days before the
expression of the F protein was measured in total extracts using an Armenian
hamster anti-F hMPVmonoclonal antibody. For DCs and LLC-MK2, 10 μg and
100 ng of total extracts were loaded, respectively. The cleaved active F1 and
uncleaved F0 proteins are indicated. DCs appeared to process the F protein more
slowly and supported significantly lower viral protein synthesis than LLC-MK2
cells. The membrane was then stripped and reprobed with anti-actin antibodies
as control (lower row). The amounts of actin were strongly reduced in the
infected cells as a result of viral replication taking over the cellular protein
synthesis machinery (shown is one of three experiments).
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significantly increased as compared to uninfected DCs, while
CD80 was up-regulated (Fig. 4). LPS-treated DCs showed
significantly increased levels of CD80, CD83, and CD86
expression, indicating that DCs were able to properly mature
under culture conditions required for hMPV growth. Further-
more, stimulation of hMPV-infected DCs with LPS resulted inFig. 3. Infected DCs release low level of infectious virions as compared to LLC-
MK cells. (A) FACS analysis of hMPV-infected DCs with an Armenian hamster
monoclonal anti-hMPV/F antibody detected the presence of the virus on 30–40%
of the DC cultures by day seven following infection at anMOI of 0.01, indicating
that, though slowly, the virus was capable to spread under these growth
conditions. Control uninfected DCs are overlapped. Shown is one of three
independent experiments. (B) Viral titration in supernatants from DCs infected
with hMPVat anMOI of 0.01 was performed at day 1, 3, and 7 postinfection. No
infectious virus was detectable within the first 3 days postinfection in any of the
cultures from four different donors. By day 7, two of the four infected DC
cultures had produced infectious virions. (C) Seven days postinfection at MOI
0.01, the number of infectious particles released in the supernatants of hMPV-
infected DCs or LLC-MK2 cells was quantified by plaque forming assay. Under
the same culture conditions, LLC-MK2 cells released a number of hMPV
particles about 2 logs higher than DCs. Shown are the means±SEM of
independent experiments with DCs (n=18) or LLC-MK2 (n=12). The broad
SEM in the titers measured in DCs reflects the wide donor variability. (D) Viral
titers (empty squares) of supernatants derived from DC infected for 7 days with
hMPVat MOI of 0.01 were determined by plaque forming assays and correlated
to the apoptosis index of the originating culture (empty circles). The apoptotic
index is indicated as the percentage of annexinV positive cells of the infected
culture relatively to the corresponding mock-infected control. There was no
correlation between viral titer and cell death (r=−0.49).the enhanced expression of all these surface markers indicating
that hMPV is not generally suppressing DC maturation (Fig. 4).
To determine whether other immunoregulatory functions of
mature DCs were affected during the hMPV infection, we
analyzed the release of cytokine in supernatants derived from
infected DCs. As shown in Fig. 5, hMPV-infected DCs strongly
up-regulated IFNα but not IFNβ, and, at much lower levels, the
release of IL-1β and IFNγ and MCP-1. However, only IFNα,
IL-1β, and IFNγ increase reached statistical significance.
hMPV infection did not affect the expression of IL-6, IL-8,
IL-10, TNFα, and RANTES, which were readily up-regulated
following LPS stimulation, again indicating that cytokine
expression was not altered by the conditions required for
hMPV growth (Fig. 5). LPS failed to significantly increase
IFNα as well as IFNβ and IL-12 (data not shown), which
Fig. 4. Infection of DCs by hMPV does not induce significant up-regulation of
co-stimulatory molecules CD83 and CD86. DCs were infected for 7 days at
MOI 0.01 before the expression of the maturation markers CD80, CD83, and
CD86 was determined by FACS analysis. While CD80 expression appeared
enhanced by hMPV, little up-regulation of CD83 and CD86 was observed in
infected DCs as compared to uninfected controls. DCs exposed overnight to LPS
(1 μg/ml) were used as positive control of maturation. Stimulation of infected
DCs with LPS, 24 h before the analysis, rescued the expression of CD83 and
CD86 (Infected+LPS). Shown are the means and SEM of five independent
experiments with DCs derived from different donors (except Infected+LPS,
where n=2).
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all, these findings suggested that hMPV did not induce efficient
maturation or activation of DCs and were consistent with the
non-activated morphology observed under light microscopy.
Discussion
In this report, we characterized the interactions of hMPV
with DCs. An important contributing factor to the late discovery
of hMPV was the difficulty of isolating and growing the virus in
commonly used laboratory adapted cell lines. In tissue culture,
growth of hMPV is slow and requires the addition of trypsin to
the media to efficiently propagate (van den Hoogen et al.,
2001). To analyze effects of hMPV infection on DCs, it was
therefore necessary to find a balance between the viral growthrequirements and the viability of the DC cultures. We based our
conditions on the optimization analysis of trypsin requirements
for hMPV performed by Biacchesi et al. (2004). In the
permissive Vero and LLC-MK2 cell lines grown in serum-free
media with trypsin and infected at an MOI of 0.01 on day 0, the
formation of multicellular foci could be detected by day 3.
Under these conditions, the virus reached a maximum titer of
105 infectious particles/ml on day seven (Biacchesi et al., 2004).
During culture in serum-free medium supplemented on day 0
with trypsin, we observed no cytotoxicity in DCs, which
maintained the characteristic morphological appearance and
normal responsiveness to LPS. DCs were permissive for hMPV
replication as evidenced by the detection of viral proteins in
Western blot analysis and specific immunostaining with the
anti-hMPV/F antibodies. Notably, the kinetics of virus expres-
sion in DCs appeared much slower than in LLC-MK2 cells.
This was confirmed by the slow release of viable infectious
particles in the supernatants of infected DCs. The more
inefficient processing of the F viral glycoprotein in infected
DCs, as compared to infected LLC-MK2, may be partly
responsible for the slow growth of the virus.
While infectious virions were detectable in DC cultures,
viral titers obtained from infected DCs were on average much
lower than those detected from LLC-MK2 cells under the
same conditions. This finding differs from the recent report
that hMPV replicates in DCs without productive infection
(Guerrero-Plata et al., 2006). The likely explanation for this
discrepancy may be attributable to the different conditions of
culture. We cultured DCs in the absence of serum and in the
presence of trypsin, which is required for viral release and
infection, rather than RPMI supplemented with serum. Though
we used a much lower MOI, our cultures are extended to 7
days as compared to a maximum of 40 hours analyzed by
Guerrero-Plata et al. (2006). Our data suggest that, similarly to
what previously observed in other permissive cells (Biacchesi
et al., 2004), longer time may be necessary for this slow-
growing virus to be released from DCs. Nevertheless, because
of the low viral levels and the difficulty to completely exclude
the presence of contaminating cells in the DC cultures, the
possibility that hMPV infection of DCs is non-productive
cannot be conclusively ruled out.
Despite the presence of the virus, infected DCs did not show
syncytia or any other characteristic hMPV cytopathic effect for
the duration of the experiments. In contrast, LLC-MK2 cells
infected at the same MOI and under the same culture conditions
presented large syncytia and cell death by day 7. However,
differently from macrophages, which can be maintained
persistently infected under the same culture conditions for
several weeks without viral cytopathicity (Horga and Gusella,
personal observation), culture of DCs showed signs of aging
with debris and cell death increasingly present in all wells,
including the uninfected controls, by day 14. While apoptosis
tended to be higher in infected DC cultures, there was no direct
correlation between viral release and cell death, and the number
of apoptotic cells appeared to be low with respect to the
percentage of infected cells (Fig. 3A). Although we did not test
earlier time points, this suggests that the virus per se may not be
Fig. 5. Induction of cytokines from DCs following infection with hMPV. Supernatants were collected 7 days after infection at MOI 0.01 and tested for the presence of
the indicated cytokines. hMPV strongly induced IFNα release from myeloid DCs. As compared to uninfected controls, hMPV infection also induced low but
statistically significant enhancement of the expression of IL-1β (p<0.01) and IFNγ (p<0.05). No statistically significant differences were observed in the expression
of IL-6, IL-8, IL-10, IFNβ, TNFα, MCP-1, and RANTES. Shown are the means and SEM of five independent experiments with DCs derived from different donors
(except IFNα and IFNβ, where n=4).
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culture conditions, we did not extend the infection experiments
beyond 1-week period. As it was reported that hMPVcytopathic effects could begin as late as 17 days postinfection
(Boivin et al., 2002), we cannot rule out further cytotoxicity of
the virus on DCs later during the culture. However, at such a late
7M.C. Tan et al. / Virology 357 (2007) 1–9time point, the biological significance of the findings would be
difficult to translate in vivo, since immature DCs located in the
periphery migrate to lymph nodes within few days upon
encounter with the antigen (Randolph, 2001). The mild toxicity
of hMPV on DCs contrasts with the effects of related
paramyxoviruses such as RSV and of human parainfluenza
virus type 3 (HPF3). In vitro, RSV and HPF3 infection of
myeloid DCs is highly lytic causing large syncytia and
apoptosis as early as 24 h postinfection (Bartz et al., 2002;
Horga et al., 2005; Plotnicky-Gilquin et al., 2001).
Upon infection, most RNA viruses infect and induce
maturation of myeloid DCs (Larsson et al., 2004). This process
is characterized by the expression of CD83 (Zhou and Tedder,
1995), up-regulation of MHC-class I and II, and co-stimulatory
molecules on the cell surface as well as the release of cytokines
(Yanagihara et al., 1998). Despite enhancing CD80 expression,
other maturation and co-stimulatory molecules such as CD83
and CD86 were only slightly up-regulated on hMPV-infected
DCs as compared to uninfected controls. Guerrero-Plata et al.
(2006) recently reported the up-regulation of all these markers
in DCs infected with hMPV. Possibly, these differences can be
accounted for by the MOI employed by these investigators,
which is 500-fold higher than the one we used in the present
report. The lack of CD83 and CD86 up-regulation by hMPV
could be readily reverted by LPS suggesting that this effect
results from the hMPV failure to activate rather than from a viral
mechanism actively suppressing maturation.
When we determined the cytokine release profile in hMPV-
infected DCs, only IFNα and, at lower levels, IL-1β and IFNγ
appeared significantly enhanced whereas the expression of
other chemokines and pro-inflammatory factors remained
overall low. In fact, we did not detect any significant induction
of IL-6, IL-8, IL-10, IL-12 (not shown), IFNβ, TNFα, MCP-1,
and RANTES in response to hMPV infection, although these
cytokines (with the exception of IFNα, IFNβ, and IL-12) were
measurable in supernatants derived from DCs exposed to LPS.
These findings indicate that hMPV infection does not induce
efficient maturation and activation of DCs even in the presence
of active viral replication and productive infection. In contrast to
hMPV, RSV and HPF3 effectively induce maturation of
myeloid DCs (Bartz et al., 2002; Horga et al., 2005;
Plotnicky-Gilquin et al., 2001). HPF3-infected DCs mature
and rapidly up-regulated the expression of pro-inflammatory
cytokines such as IL-8, IL-6, TNFα, IFNγ, and RANTES
(Horga et al., 2005). RSV-infected DCs show morphological
and immunophenotypic changes consistent with maturation and
express PGE2, IL-11, and low levels of IL-12 (Bartz et al.,
2002). Because DCs play a pivotal role in the initiation of
immune responses following infection, viral interference with
DC maturation has been proposed as a mechanism allowing the
virus to replicate more efficiently in the host (Larsson et al.,
2004).
The disease spectrum caused by HPF3 and RSV ranges from
mild upper respiratory tract infections to more severe laryngo-
tracheobronchitis, bronchiolitis, and bronchopneumonitis. In
animal models, RSVand HPF3 cause significant tissue damage
and inflammatory infiltrates (Hall, 2001; Openshaw et al., 1992;Prince et al., 1986, 2001; Tripp et al., 2005). The potent
inflammatory response elicited after RSVand HPF3 infection is
thought to be largely responsible for pathogenesis (Hall, 2001).
In contrast, infection with hMPV causes modest cytopathic
effects and mild bronchial inflammation in mice lung
histopathology (Alvarez et al., 2004). Furthermore, hMPV
can be found in lungs of BALB/c mice up to 60 days
postinfection suggesting a possible role of persistence in the
pathogenesis caused by this virus (Alvarez et al., 2004).
Whether anergy is part of a mechanism evolved to allow hMPV
to persist remains to be established. Inflammatory cytokines,
such as IL-1β, IL-6, IL-8, IL-12, and TNFα, measured in the
nasal washes from naive infants exposed to hMPV were found
to be 2–6-fold less than in nasal washes from infants infected
with RSV or influenza (Laham et al., 2004). In BALB/c mice,
hMPV infection induced weak adaptive responses characterized
by delayed development of antiviral cytotoxic T lymphocyte
and antibodies response (Alvarez and Tripp, 2005). These and
our findings support the low immunogenicity of hMPV.
Due to its recent recognition and isolation, the immunobiol-
ogy of hMPV remains largely unknown and further work will be
necessary to elucidate the mechanisms by which hMPV avoids
activation of DCs and its potential role in persistence and
pathogenesis. Our data suggest that vaccine candidates will
need to specifically overcome the hypostimulation of DCs to
mount a significant immune response and achieve higher
effectiveness.
Materials and methods
DCs generation and characterization
Peripheral blood mononuclear cells (PBMC) were purified
on Ficoll density gradient and used for the isolation of
monocytes through positive selection with CD14 antibodies on
magnetic cell separator (Stem Cell Technology, Vancouver,
BC, Canada) according to the manufacturer's instructions.
Purity, as assessed by FACS using an anti-CD14 specific
antibody (BD Biosciences Pharmingen, San Diego, CA), was
in the range of 95–99%. Human monocytes were cultured for
7 days in complete medium (RPMI-1640, 10% fetal calf
serum, 2 mM glutamine, 10 mM HEPES pH7.2) supplemented
with 1000 U/ml of recombinant human GM-CSF (Roche
Applied Science, Indianapolis, IN) and 200 ng/ml of
recombinant human interleukin-4 (IL-4) (R&D Systems,
Minneapolis, MN). DCs phenotypic analysis was performed
using fluorescence-labeled antibodies for CD11c and class II
HLA-DR (BD Biosciences Pharmingen, San Diego, CA). Flow
cytometer analysis was performed on a Becton Dickinson
FACScalibur.
HMPV stocks and titers
Stocks of hMPV were produced from the hMPV strain
BA02 (generously donated by Dr. Fernando Polack). Virus was
propagated by inoculation of the rhesus monkey kidney cell
line LLC-MK2, which is permissive for viral growth. Cell
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medium (Invitrogen, Carlsbad, CA) supplemented with 2.5 μg/
ml trypsin (Sigma, St. Louis, MO). Trypsin, at a final
concentration of 2.5 μg/ml, was added to the medium every
2 days to enhance viral growth and maximize titers as
described (Biacchesi et al., 2004). Cultures were carried for
10 days and analyzed periodically under light microscopy to
monitor hMPV cytopathic effects. Supernatants containing
virus were collected 7 days postinfection, filtered through a
0.45 μm filter, and stored at −80 °C. Viral titer was determined
by plaque assay in 96 well plates of LLC-MK2 cells under
methyl cellulose overlay. Plaques were visualized 7 days later
by immunostaining with Armenian hamster anti-hMPV/F
monoclonal antibody (kindly provided by Dr. N. Ulbrandt,
MedImmune, Gaithersburg, MD) (Schickli et al., 2005) and
FITC-conjugated anti-Armenian hamster secondary antibodies
(Jackson Immune Research, West Grove, PA). Titers were
calculated as mean of duplicate wells.
Infection of DCs and measurement of viral replication
Immature 7-day old DCs were plated at a density of 5×105
cells/well in 12-well plates in OptiMEM supplemented with
2.5 μg/ml trypsin and cytokines (IL-4 and GMCSF), and
infected at 37 °C for 90 min with hMPV at a multiplicity of
infection (MOI) of 0.01, as previously described (Biacchesi et
al., 2004). Supernatants with unbound virus were then carefully
removed and 2 ml of fresh OptiMEM supplemented with
2.5 μg/ml trypsin and cytokines were added to the infected cells
and the infection allowed to proceed at 37 °C. Supernatants
were harvested at the times indicated in the figure legends and
stored for cytokine measurement and assessment of viral titer.
As control of viral titers, 5×105 LLC-MK2 cells/well were
plated in 12-well plates, infected and harvested under the exact
same culture conditions.
Immunostaining
DC maturation was assessed by phenotypic analysis using
fluorescence-labeled antibodies for CD80, CD83, and CD86
(BD Biosciences Pharmingen, San Diego, CA). Mock-infected
cells and cells incubated with the isotype control antibody were
used as negative controls. As positive control for maturation,
DCs grown in the same culture conditions were exposed to LPS
(Sigma) at a final concentration of 1 μg/ml. FACS analysis was
performed on a Becton Dickinson FACS Calibur flow
cytometer. The expression of viral glycoproteins on the surface
of infected DCs was measured using a primary Armenian
hamster anti-hMPV/F monoclonal antibody (Schickli et al.,
2005) and a secondary FITC-conjugated anti-Armenian hamster
antibody (Jackson Immune Research).
AnnexinV staining
To assess apoptotic cell death, cells were harvested and
washed with PBS and analyzed to determine the annexinV
positive cells. AnnexinVand propidium iodide (PI) staining wasperformed using the Annexin-V-Fluos Staining kit (Boehringer
Manheim) according to the provided protocol. AnnexinV-PI
stained cells were then transferred to polystyrene tubes with
cell-strainer caps (Falcon) and subjected to FACS using Cell
Quest 3.2 software (Beckton Dickinson) for acquisition and
analysis. Cells positively stained with AnnexinV and not PI
were considered apoptotic, and cells negative for the two dyes
were considered live cells.
Cytokine analysis
Supernatants from DC cultures infected with hMPV were
harvested 7 days postinfection. With the exception of IFNα and
IFNβ, which were measured using ELISA kits from PBL
Biomedical Laboratories (Piscataway, NJ), cytokine analyses
were performed using a Beadlyte Human Multi-cytokine
Detection System Kit (Upstate, Lake Placid, New York), and
results were read in a Luminex 100 System (Luminex
Corporation, Austin, TX) according to the manufacturer's
instructions.
Immunodetection
For Western blot analysis of hMPV-infected DCs, 500,000
DCs were collected 7 days after infection. DCs were centrifuged
at 1200 rpm (Beckman GS-6R centrifuge) at 4 °C for 5 min. The
cell pellet was washed once with 3 ml of phosphate buffer
solution (PBS) and lysed with 400 μl of RIPA buffer (150 mM
NaCl, 10 mM Tris–Cl pH 7.2, 1% Triton X-100, 0.1% SDS, 1%
Na-deoxycholate, 5 mM EDTA) supplemented with protease
inhibitors cocktail (Roche Diagnostics, Indianapolis, IN).
Lysates were incubated on ice for 10 min and cleared by
centrifugation at 14,000 rpm for 10 min. Protein concentration
in the supernatants was determined using the Bio-Rad protein
assay (Hercules, CA). Equal amounts of protein extracts (10 μg
for DCs and 100 ng for LLC-MK2) were loaded per lane,
electrophoresed on a 4–12% SDS-polyacrylamide gel, and
transferred onto a PVDF membrane (Millipore). The mem-
branes were blocked in PBST (PBS, 0.05% Tween-20) with
10% dry milk for 1 h, rinsed once with PBST, incubated with
the Armenian hamster anti-hMPV/F monoclonal antibody
(MedImmune) (Schickli et al., 2005) diluted 1:500 in 1%
bovine serum albumin (BSA) in PBST for 1 h at room
temperature. A secondary peroxidase-conjugated goat anti-
Armenian hamster (Jackson Immune Research) diluted
1:10,000 was then used to detect the primary antibody using
the Lumilight developing system (Roche Diagnostics) accord-
ing to the manufacturer's instructions. Following stripping and
blocking, the expression of actin was determined using an anti-
actin monoclonal antibody (Chemicon, Temecula, CA) under
the conditions recommended by the manufacturer.
Statistical analysis
The two-tail unpaired t test with Welch correction was
applied for statistical analyses using the InStat 3.0 software
(GraphPad Software Inc, San Diego, CA).
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